Stock & Company Details
Medpace Holdings Inc $MEDP
Price:
N/A
N/A
28M
$17B
52 Week High:
N/A
10 Day Average Volume:
N/A
35.35
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Commercial Services
MEDP technical indicators
Latest Medpace Holdings Inc (MEDP) indicator readings as of 2026-10-09.
MEDP's 14-day RSI is 52.4, in neutral territory. At $612.05 it is trading 16.6% above its 200-day moving average of $524.95, and above its 50-day average of $602.49. Price sits in the middle of its Bollinger Bands ($594.32 to $632.98). ADX reads 22.4, sitting between trending and range-bound.
MEDP backtested strategy results
How 4 rule-based strategies performed on Medpace Holdings Inc (MEDP) over recent history, last backtested 2026-09-06. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +93.8% | 50% | 8 | -35.0% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +83.6% | 35% | 31 | -36.8% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -44.5% | 27% | 37 | -66.4% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +92.9% | 79% | 24 | -12.8% |
Overview
Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.
Finance Bot
Ask your questions
Start by typing a question below.
